Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 2/2018

Ausgabe 2/2018

Inhaltsverzeichnis ( 19 Artikel )

13.04.2018 | editorial | Ausgabe 2/2018

Laboratory diagnostics in hematology—a new “Educational” series

Gerald Webersinke PhD

24.05.2018 | editorial | Ausgabe 2/2018

The adolescence of cancer immunotherapy: from a difficult childhood to a pillar of modern anticancer therapy

Thorsten Fuereder MD

01.06.2018 | editorial | Ausgabe 2/2018

Update and clinical highlights presented at the 2017 American Society of Hematology Meeting

Dr. Daniel Heintel

13.04.2018 | educational | Ausgabe 2/2018

Educational no. 1: Bone marrow diagnostics in hemato-oncological diseases

Cytology, trephine biopsy
Michael Vockenhuber MD, Kurt Wiesinger MD, Christine Gruber MD

06.06.2018 | short review | Ausgabe 2/2018

Update of clinical highlights presented at the 2017 American Society of Hematology Meeting

Focus multiple myeloma
Dr. Sabine Burger, PD Dr. Niklas Zojer, Univ.-Prof. Dr. Heinz Ludwig

23.05.2018 | short review | Ausgabe 2/2018

ASH 2017: highlights in chronic myeloid leukemia

Klaus Geissler

25.05.2018 | short review | Ausgabe 2/2018

Acute myeloid leukemia—current data from the 2017 American Society of Hematology meeting

Univ.-Prof. Dr. Michael Pfeilstöcker MBA

21.03.2018 | short review | Ausgabe 2/2018

Indolent lymphoma at ASH (American Society of Hematology) 2017: maintenance revisited

Thomas Nösslinger MD

01.06.2018 | short review | Ausgabe 2/2018 Open Access

Chronic lymphocytic leukemia at ASH 2017

David Wanner MD, Michael Steurer

28.05.2018 | special report | Ausgabe 2/2018

My burning issues in aggressive Non Hodgkin’s Lymphoma

David Fuchs, Michael A. Fridrik

18.05.2018 | short review | Ausgabe 2/2018 Open Access

Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives

Andreas Tiefenbacher, Prof. Dr. Robert Pirker

06.06.2018 | short review | Ausgabe 2/2018 Open Access

Chimeric antigen receptor T‑cell therapy—a hematological success story

Philipp Wohlfarth MD, Nina Worel, Georg Hopfinger

23.05.2018 | review | Ausgabe 2/2018

Current and future developments of immunotherapy in lung cancer

Laetitia A. Mauti, Tobias Finazzi, Martin Früh, Miklos Pless, Alfred Zippelius, Sacha I. Rothschild

12.06.2018 | short review | Ausgabe 2/2018 Open Access

Management of adverse events related to checkpoint inhibition therapy

OA Dr. Jakob Daniel Rudzki

21.03.2018 | short review | Ausgabe 2/2018 Open Access

Pitfalls in the radiological response assessment of immunotherapy

Lucian Beer MD, PhD, Maximilian Hochmair MD, Helmut Prosch MD

02.03.2018 | original report | Ausgabe 2/2018 Open Access

APPLY: A prospective observational study of clinical practice patterns of darbepoetin alfa use in patients with chemotherapy-induced anemia in Romania

Nicoleta Mariana Berbec, Dana Lucia Stanculeanu, Nicoleta Sorina Badelita, Mariana Vasilica, Dorel Ionel Popovici, Andrei Colita, Cristina Neacsu, Alexandru Iordan

22.03.2018 | review | Ausgabe 2/2018

JAK2V617F allele burden: innovative concept in monitoring of myeloproliferative neoplasms

Soheila Bagheropur, Ali Ehsanpour, Maryam Tahmasebi Birgani, Najmaldin Saki

23.04.2018 | case report | Ausgabe 2/2018

Pulmonary mass: never judge a book by its cover

Inke De haes, Yvan Valcke, Koen Deschepper, Elisabeth Beerens, Pieter Goeminne

30.08.2016 | comment – reprint | Ausgabe 2/2018

Developments in neuro-oncology

Silvia Hofer MD

Aktuelle Ausgaben